AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 8,077.30
-110.85 (-1.35%)
At close: Aug 10, 2026
AstraZeneca Pharma India Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | - | 4,477 | 5,361 | 5,056 | 5,003 | 4,484 |
Cash & Short-Term Investments | 4,477 | 4,477 | 5,361 | 5,056 | 5,003 | 4,484 |
Cash Growth | -16.49% | -16.49% | 6.05% | 1.04% | 11.58% | 27.27% |
Accounts Receivable | - | 2,137 | 1,849 | 1,531 | 1,075 | 858.9 |
Other Receivables | - | 78.9 | 143.6 | 160.4 | 105.1 | 121.8 |
Receivables | - | 2,216 | 1,995 | 1,693 | 1,181 | 981.6 |
Inventory | - | 10,273 | 5,485 | 2,279 | 1,902 | 1,402 |
Prepaid Expenses | - | 112 | 142.1 | 109.6 | 117.7 | 108.2 |
Other Current Assets | - | 321.1 | 439.6 | 190 | 150.4 | 80.5 |
Total Current Assets | - | 17,399 | 13,424 | 9,327 | 8,355 | 7,057 |
Property, Plant & Equipment | - | 1,175 | 635.8 | 648.4 | 701.9 | 766.9 |
Other Intangible Assets | - | - | 6.6 | 21.1 | - | - |
Long-Term Deferred Tax Assets | - | 378 | 415.6 | 212.5 | 206.7 | 163 |
Other Long-Term Assets | - | 939 | 698.6 | 568.5 | 576.6 | 574.9 |
Total Assets | - | 19,891 | 15,181 | 10,780 | 9,849 | 8,566 |
Accounts Payable | - | 7,827 | 4,563 | 1,965 | 2,279 | 1,904 |
Accrued Expenses | - | 607.5 | 602.7 | 767.2 | 852.3 | 785.3 |
Current Portion of Leases | - | 139.1 | 62.8 | 18.1 | 35.2 | 36.1 |
Current Income Taxes Payable | - | 54.1 | 106.4 | 66.6 | 24.2 | 49.4 |
Current Unearned Revenue | - | 617.2 | 722.4 | 490.5 | 398 | 306.9 |
Other Current Liabilities | - | 573.2 | 972.7 | 263.7 | 250.8 | 244.4 |
Total Current Liabilities | - | 9,818 | 7,030 | 3,571 | 3,839 | 3,327 |
Long-Term Leases | - | 967.5 | 294.5 | 27.8 | 36.9 | 50.2 |
Pension & Post-Retirement Benefits | - | 148.4 | 53.7 | 44.4 | 69 | 48.2 |
Other Long-Term Liabilities | - | 229.1 | 99.5 | 17.7 | 16.6 | 26.8 |
Total Liabilities | - | 11,163 | 7,478 | 3,661 | 3,962 | 3,452 |
Common Stock | - | 50 | 50 | 50 | 50 | 50 |
Retained Earnings | - | 7,889 | 6,859 | 6,313 | 5,088 | 4,321 |
Comprehensive Income & Other | - | 788.6 | 795 | 756.4 | 749.2 | 743 |
Shareholders' Equity | 8,728 | 8,728 | 7,704 | 7,119 | 5,887 | 5,114 |
Total Liabilities & Equity | - | 19,891 | 15,181 | 10,780 | 9,849 | 8,566 |
Total Debt | 1,107 | 1,107 | 357.3 | 45.9 | 72.1 | 86.3 |
Net Cash (Debt) | 3,371 | 3,371 | 5,004 | 5,010 | 4,931 | 4,398 |
Net Cash Growth | -32.64% | -32.64% | -0.11% | 1.59% | 12.13% | 29.27% |
Net Cash Per Share | 134.82 | 134.82 | 200.16 | 200.39 | 197.25 | 175.92 |
Filing Date Shares Outstanding | 25 | 25 | 25 | 25 | 25 | 25 |
Total Common Shares Outstanding | 25 | 25 | 25 | 25 | 25 | 25 |
Working Capital | - | 7,581 | 6,394 | 5,756 | 4,515 | 3,730 |
Book Value Per Share | 349.12 | 349.12 | 308.14 | 284.77 | 235.48 | 204.56 |
Tangible Book Value | 8,728 | 8,728 | 7,697 | 7,098 | 5,887 | 5,114 |
Tangible Book Value Per Share | 349.12 | 349.12 | 307.88 | 283.92 | 235.48 | 204.56 |
Land | - | 0.3 | 4.9 | 4.9 | 4.9 | 4.9 |
Buildings | - | 12 | 427 | 427 | 421.3 | 415.2 |
Machinery | - | 402.3 | 1,155 | 1,208 | 1,154 | 1,082 |
Construction In Progress | - | - | - | 2.7 | 13.3 | 22 |